Division of Structural Biology, Department of Biosciences, University of Salzburg, Billrothstrasse 11, 5020, Salzburg, Austria.
Division of Structural Biology, Department of Biosciences, University of Salzburg, Billrothstrasse 11, 5020, Salzburg, Austria.
Biochimie. 2019 Nov;166:52-76. doi: 10.1016/j.biochi.2019.09.004. Epub 2019 Sep 7.
Trypsin and chymotrypsin-like serine proteases from family S1 (clan PA) constitute the largest protease group in humans and more generally in vertebrates. The prototypes chymotrypsin, trypsin and elastase represent simple digestive proteases in the gut, where they cleave nearly any protein. Multidomain trypsin-like proteases are key players in the tightly controlled blood coagulation and complement systems, as well as related proteases that are secreted from diverse immune cells. Some serine proteases are expressed in nearly all tissues and fluids of the human body, such as the human kallikreins and kallikrein-related peptidases with specialization for often unique substrates and accurate timing of activity. HtrA and membrane-anchored serine proteases fulfill important physiological tasks with emerging roles in cancer. The high diversity of all family members, which share the tandem β-barrel architecture of the chymotrypsin-fold in the catalytic domain, is conferred by the large differences of eight surface loops, surrounding the active site. The length of these loops alters with insertions and deletions, resulting in remarkably different three-dimensional arrangements. In addition, metal binding sites for Na, Ca and Zn serve as regulatory elements, as do N-glycosylation sites. Depending on the individual tasks of the protease, the surface loops determine substrate specificity, control the turnover and allow regulation of activation, activity and degradation by other proteins, which are often serine proteases themselves. Most intriguingly, in some serine proteases, the surface loops interact as allosteric network, partially tuned by protein co-factors. Knowledge of these subtle and complicated molecular motions may allow nowadays for new and specific pharmaceutical or medical approaches.
丝氨酸蛋白酶家族 S1(PA 族)中的胰凝乳蛋白酶和胰蛋白酶样蛋白酶构成了人类和更广泛的脊椎动物中最大的蛋白酶家族。原型酶糜蛋白酶、胰蛋白酶和弹性蛋白酶代表肠道中的简单消化蛋白酶,它们可以切割几乎所有的蛋白质。多结构域胰蛋白酶样蛋白酶是紧密控制的血液凝固和补体系统中的关键因子,以及相关的从各种免疫细胞分泌的蛋白酶。一些丝氨酸蛋白酶几乎在人体的所有组织和体液中表达,如人类激肽释放酶和激肽释放酶相关肽酶,它们对通常独特的底物具有特异性,并能准确控制其活性的时间。丝氨酸蛋白酶 HtrA 和膜锚定蛋白酶在癌症中具有新兴作用,履行着重要的生理任务。所有家族成员的高度多样性,它们在催化结构域中共享糜蛋白酶折叠的串联β-桶结构,是由八个表面环的巨大差异赋予的,这些表面环围绕着活性位点。这些环的长度随插入和缺失而变化,导致显著不同的三维排列。此外,用于 Na、Ca 和 Zn 的金属结合位点作为调节元件,N-糖基化位点也是如此。根据蛋白酶的个体任务,表面环决定了底物特异性,控制周转率,并允许通过其他蛋白质(通常也是丝氨酸蛋白酶本身)来调节激活、活性和降解。最有趣的是,在一些丝氨酸蛋白酶中,表面环作为别构网络相互作用,部分由蛋白质共因子调节。对这些微妙而复杂的分子运动的了解,如今可能为新的和特定的药物或医疗方法提供了可能性。